Kefeng Ding
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Colorectal Cancer Screening and Detection
Papers in ⓘ
- Oncology 103
- Colorectal Cancer Screening and Detection 31
- Colorectal Cancer Surgical Treatments 27
- Colorectal Cancer Treatments and Studies 27
-
- RNA modifications and cancer 14
- Co-authors
- Xiangxing Kong (27 shared papers)Qian Xiao (47 shared papers)Kai Jiang (15 shared papers)Ying Yuan (31 shared papers)Yeting Hu (32 shared papers)Wei Lu (10 shared papers)Shu Zheng (23 shared papers)Honghe Zhang (5 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Oncotarget (7 papers)Frontiers in Oncology (6 papers)International Journal of Cancer (5 papers)BMC Cancer (5 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Kefeng Ding
173 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 1.2k
- Oncology 1.2k
- Molecular Biology 1.6k
- Pathology and Forensic Medicine 350
- Pulmonary and Respiratory Medicine 538
Countries citing papers authored by Kefeng Ding
This map shows the geographic impact of Kefeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefeng Ding more than expected).
Fields of papers citing papers by Kefeng Ding
This network shows the impact of papers produced by Kefeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefeng Ding. The network helps show where Kefeng Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Kefeng Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells Hit paper breakdown → | 2022 | 506 |
| 2 | 2017 | 253 | |
| 3 | Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019 Hit paper breakdown → | 2023 | 119 |
| 4 | 2020 | 110 | |
| 5 | 2021 | 107 | |
| 6 | 2021 | 91 | |
| 7 | Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome Hit paper breakdown → | 2023 | 91 |
| 8 | 2017 | 81 | |
| 9 | 2019 | 80 | |
| 10 | 2016 | 65 | |
| 11 | 2021 | 63 | |
| 12 | 2023 | 62 | |
| 13 | 2020 | 58 | |
| 14 | 2019 | 50 | |
| 15 | 2020 | 50 | |
| 16 | 2016 | 49 | |
| 17 | 2022 | 47 | |
| 18 | 2020 | 42 | |
| 19 | 2021 | 40 | |
| 20 | 2021 | 39 |
About Kefeng Ding
Kefeng Ding is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 185 papers that have together received 3.6k indexed citations. Recurring topics across this work include Colorectal Cancer Screening and Detection (31 papers), Gastric Cancer Management and Outcomes (29 papers), Genetic factors in colorectal cancer (27 papers), Colorectal Cancer Surgical Treatments (27 papers), Colorectal Cancer Treatments and Studies (27 papers), Colorectal and Anal Carcinomas (15 papers), RNA modifications and cancer (14 papers) and Cancer-related molecular mechanisms research (14 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.2k citations), Molecular Biology (1.6k citations), Pathology and Forensic Medicine (350 citations) and Pulmonary and Respiratory Medicine (538 citations). Kefeng Ding has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xiangxing Kong, Qian Xiao, Kai Jiang, Ying Yuan, Yeting Hu, Wei Lu, Shu Zheng, Honghe Zhang, Liubo Chen and Bijun Cui. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Frontiers in Oncology, International Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.